Showing results (211-220 of 273) with videos related to
Sort By:
Pageof 28
The Journal of Pharmacy and Pharmacology|May 1, 1985
Dopamine receptor agonistic activities of R- and S-enantiomers of 4-hydroxy-2-di-n-propylaminoindan in cat heartsM Ilhan, J R Flynn, J P Long, et al.Drug Design and Delivery|February 1, 1987
Structure-activity relationship studies in the hemicholinium ('HC-3') seriesJ G Cannon, T M Lee, A M Nyanda, et al.Urology|March 15, 2001
Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostateJ P Long, D Bahn, F Lee, et al.European Journal of Pharmacology|June 1, 1976
The antagonism of nicotine-induced cardiovascular responses by DMAE and DEO analogsL A Peterson, F M Sharabi, J P Long, et al.The Journal of Pharmacology and Experimental Therapeutics|April 1, 1985
Effects of metyrapone on the pharmacological activity, plasma levels and urinary excretion of the dopamine receptor agonist DK-118J C Koons, J P Long, D L Koble, et al.Journal of Medicinal Chemistry|December 1, 1982
Conformationally restricted congeners of dopamine derived from 2-aminoindanJ G Cannon, J A Perez, R K Bhatnagar, et al.Life Sciences|April 23, 1984
Possible biologically active metabolites of 5-hydroxy-6-methyl-2-di-n-propylaminotetralinJ G Cannon, D C Furlano, D L Koble, et al.The Journal of Pharmacology and Experimental Therapeutics|November 1, 1988
Alterations in acetylcholine metabolism in rat striatal slices by a 4-methyl piperidine analog of hemicholinium-3C E Tedford, J R Flynn, R K Bhatnagar, et al.Journal of Medicinal Chemistry|February 1, 1990
Hemicholinium-3 congeners as potential antagonists to organophosphate-induced toxicityJ G Cannon, M F Sahin, J P Long, et al.European Journal of Pharmacology|September 9, 1986
Evaluation of 4-methylpiperidine analogs of hemicholinium-3C E Tedford, D Reed, B Bhattacharyya, et al.Pageof 28